KBC Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.5M | Sell |
294,497
-3,842
| -1% | -$268K | 0.05% | 275 |
|
|
2025
Q4 | $19.8M | Sell |
298,339
-133,500
| -31% | -$8.63M | 0.05% | 271 |
|
|
2025
Q3 | $29.1M | Buy |
431,839
+23,490
| +6% | +$1.86M | 0.07% | 219 |
|
|
2025
Q2 | $35.6M | Buy |
408,349
+831
| +0.2% | +$65.1K | 0.1% | 198 |
|
|
2025
Q1 | $27.8M | Sell |
407,518
-10,170
| -2% | -$830K | 0.09% | 225 |
|
|
2024
Q4 | $32.5M | Sell |
417,688
-79,068
| -16% | -$5.85M | 0.09% | 216 |
|
|
2024
Q3 | $33.3M | Buy |
496,756
+148,569
| +43% | +$12.2M | 0.1% | 196 |
|
|
2024
Q2 | $39.5M | Buy |
348,187
+939
| +0.3% | +$119K | 0.12% | 159 |
|
|
2024
Q1 | $48.2M | Buy |
347,248
+28,229
| +9% | +$3.55M | 0.15% | 140 |
|
|
2023
Q4 | $39.6M | Sell |
319,019
-44,418
| -12% | -$4.54M | 0.14% | 161 |
|
|
2023
Q3 | $33.9M | Sell |
363,437
-107,637
| -23% | -$12.1M | 0.14% | 161 |
|
|
2023
Q2 | $60.5M | Buy |
471,074
+11,170
| +2% | +$1.35M | 0.25% | 87 |
|
|
2023
Q1 | $53.4M | Buy |
459,904
+63,247
| +16% | +$7.08M | 0.23% | 95 |
|
|
2022
Q4 | $44.9M | Sell |
396,657
-32,829
| -8% | -$3.6M | 0.22% | 105 |
|
|
2022
Q3 | $34.6M | Buy |
429,486
+35,088
| +9% | +$2.97M | 0.18% | 127 |
|
|
2022
Q2 | $29.4M | Buy |
394,398
+68,086
| +21% | +$6.21M | 0.15% | 166 |
|
|
2022
Q1 | $41.7M | Sell |
326,312
-314,684
| -49% | -$34.4M | 0.17% | 151 |
|
|
2021
Q4 | $86M | Buy |
640,996
+188,944
| +42% | +$27.2M | 0.28% | 93 |
|
|
2021
Q3 | $61.8M | Sell |
452,052
-410,940
| -48% | -$51.8M | 0.23% | 107 |
|
|
2021
Q2 | $92.1M | Buy |
862,992
+17,152
| +2% | +$1.65M | 0.17% | 139 |
|
|
2021
Q1 | $76M | Buy |
845,840
+143,888
| +20% | +$13.5M | 0.15% | 166 |
|
|
2020
Q4 | $357M | Buy |
701,952
+82,376
| +13% | +$7.36M | 0.15% | 166 |
|
|
2020
Q3 | $63.9M | Buy |
619,576
+89,296
| +17% | +$9.33M | 0.19% | 125 |
|
|
2020
Q2 | $53.7M | Buy |
530,280
+354,248
| +201% | +$31.7M | 0.18% | 123 |
|
|
2020
Q1 | $11.8M | Sell |
176,032
-16,956
| -9% | -$1.06M | 0.1% | 216 |
|
|
2019
Q4 | $10.6M | Buy |
192,988
+10,016
| +5% | +$475K | 0.07% | 315 |
|
|
2019
Q3 | $6.83M | Sell |
182,972
-5,860
| -3% | -$228K | 0.05% | 386 |
|
|
2019
Q2 | $7.07M | Buy |
188,832
+9,732
| +5% | +$306K | 0.05% | 373 |
|
|
2019
Q1 | $5.33M | Sell |
179,100
-131,256
| -42% | -$4.61M | 0.04% | 406 |
|
|
2018
Q4 | $9.29M | Buy |
310,356
+71,784
| +30% | +$2.28M | 0.1% | 243 |
|
|
2018
Q3 | $8.53M | Buy |
238,572
+5,048
| +2% | +$157K | 0.06% | 316 |
|
|
2018
Q2 | $5.54M | Buy |
233,524
+229,836
| +6,232% | +$4.87M | 0.05% | 386 |
|
|
2018
Q1 | $68K | Hold |
3,688
| – | – | ﹤0.01% | 1200 |
|
|
2017
Q4 | $53K | Sell |
3,688
-31,564
| -90% | -$410K | ﹤0.01% | 1202 |
|
|
2017
Q3 | $431K | Sell |
35,252
-2,304
| -6% | -$40.7K | ﹤0.01% | 994 |
|
|
2017
Q2 | $687K | Buy |
37,556
+4,324
| +13% | +$79.9K | 0.01% | 884 |
|
|
2017
Q1 | $704K | Buy |
33,232
+8,708
| +36% | +$170K | 0.01% | 967 |
|
|
2016
Q4 | $366K | Buy |
+24,524
| New | +$434K | ﹤0.01% | 1099 |
|
Other funds holding DXCM
VCM
VPM
KBC Group's DXCM Position: Q1 2026 in Review
KBC Group reduced its DexCom (DXCM) stake by 1.3% in Q1 2026, selling an estimated $268K and leaving 294,497 shares worth $18.5M. The position accounts for 0.05% of the portfolio, ranked #275.
KBC Group first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $357M in Q4 2020. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- KBC Group held 294,497 shares of DexCom worth $18.5M as of Q1 2026.
- KBC Group sold 3,842 DexCom shares in Q1 2026, an estimated $268K.
- DexCom made up 0.05% of KBC Group's portfolio in Q1 2026, its #275 holding.
- KBC Group first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
- KBC Group's DexCom position peaked at $357M in Q4 2020.
- 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.